HB 3233 amends the Texas Insurance Code by adding a new Section 4151.1531 to Subchapter D, Chapter 4151, which governs Pharmacy Benefit Managers (PBMs). The bill addresses the growing concern over data privacy and national security by prohibiting PBMs from storing or processing patient data for Texas residents in foreign countries designated by the U.S. Secretary of State as state sponsors of terrorism. This designation is made pursuant to three federal statutes: Section 620A of the Foreign Assistance Act of 1961 (22 U.S.C. § 2371), Section 40 of the Arms Export Control Act (22 U.S.C. § 2780), and Section 1754(c) of the John S. McCain National Defense Authorization Act for Fiscal Year 2019.
The legislation aims to protect the privacy and security of sensitive health information by ensuring that Texas resident data remains within jurisdictions that respect international norms of data protection and civil liberties. By tying the prohibited countries to federal determinations of terrorism sponsorship, the bill avoids ambiguity and aligns with national security frameworks already in place at the federal level.
Importantly, the bill applies only to contracts entered into or renewed on or after its effective date of September 1, 2025. This allows regulated entities sufficient time to adjust data management practices and ensure compliance. The provision does not impose new reporting requirements, enforcement agencies, or penalties, relying instead on the pre-existing regulatory structure governing PBMs under Texas law. In sum, HB 3233 introduces a focused and preventative measure to protect Texans’ health information from access or misuse by foreign adversaries.
The originally filed version of HB 3233 prohibited pharmacy benefit managers (PBMs) from storing or processing patient data for Texas residents in any location "outside of the United States". This version applied a broad geographic restriction, effectively banning the use of any foreign data centers, including those in allied or neutral countries such as Canada, the United Kingdom, or Germany.
In contrast, the Committee Substitute version of HB 3233 narrows the scope of the restriction by specifying that PBMs may not store or process patient data in countries designated by the U.S. Secretary of State as state sponsors of terrorism. This is a more targeted and calibrated approach that limits the prohibition only to a small group of high-risk nations, such as Iran, North Korea, and Syria, which have been officially identified by the federal government under statutory authority (e.g., the Foreign Assistance Act and the Arms Export Control Act).
Additionally, the substitute version clarifies that the restriction applies only to contracts entered into or renewed on or after the effective date of the Act, which remains September 1, 2025. This prospective application provides more certainty to regulated entities and avoids retroactive disruption of existing data arrangements—language that was absent from the originally filed version.
In summary, the key differences lie in the scope and specificity of the restriction: the original bill imposed a blanket prohibition on data storage outside the U.S., while the Committee Substitute adopts a more precise, risk-based framework rooted in national security designations. This shift reflects a policy balance between data protection and practical compliance flexibility.